Skip to main content
logo
Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.1150
0.00 (0.00%)
Sep 16, 2026, 12:33 PM AEST

Invex Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.050.050.231.210.460.18
Revenue Growth
-79.56%-79.56%-81.10%164.06%151.90%-
Gross Profit
0.050.050.231.210.460.18
Operating Income
-1.5-1.5-0.71-2.13-8.55-4.03
Net Income
-1.35-1.35-0.48-1.64-7.75-3.95
Earnings Per Share
-0.02-0.02-0.01-0.02-0.10-0.05
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
4.024.025.386.0322.4729.34
Net Cash Growth
-12.60%-25.28%-10.79%-73.19%-23.41%-10.32%
Net Cash Per Share
0.050.050.070.080.300.39
Cash & Investments
4.024.025.386.0322.4729.34

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-1.36-1.36-0.65-2.44-6.87-3.38
Free Cash Flow
-1.36-1.36-0.65-2.44-6.87-3.38
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-3198.22%-3198.22%-309.63%-176.00%-1861.73%-2212.89%
Pretax Margin
-2888.04%-2888.04%-208.16%-135.43%-1688.11%-2169.06%
Profit Margin
-2888.04%-2888.04%-208.16%-135.43%-1688.11%-2169.06%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
184.57144.4529.203.7232.74204.12